Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 474, pseudogene (RN7SL474P) is one of many dispersed sequences within the human genome that resemble the 7SL RNA gene, but, due to truncations and sequence divergence, do not produce functional 7SL RNA. 7SL RNA itself forms the backbone of the signal recognition particle (SRP), essential for targeting secretory and membrane proteins to the endoplasmic reticulum[3][5]. The majority of 7SL-related sequences in the genome are classified as pseudogenes and result from reverse transcription and reinsertion of RNA sequences. Most are not transcribed or not functional if transcribed[7][9]. As a pseudogene, RN7SL474P may either have no effect or, consistent with some other pseudogenes, participate in the regulation of gene expression at the RNA level, but has not been demonstrated to do so functionally[1][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 474, pseudogene (RN7SL474P).